Efficacy and Safety of Stempeucel ® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease
Conditions: Critical Limb Ischemia; Buerger's Disease Intervention: Biological: Adult human bone marrow derived, cultured, pooled, allogeneic mesenchymal stromal cells Sponsors: Cell Biopeutics Resources Sdn Bhd; Stempeutics Research Pvt Ltd; National University of Malaysia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials